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ABSTRACT  
Objective: The purpose of this study was to investigate and select the suitable granulating fluid for the matrix granules 
consisting of hydroxypropyl methylcellulose (HPMC). Method: Viscosity of the granulating fluids containing HPMC in different 
solvents was determined. The matrix granules obtained from mixing the granulating fluid with propranolol HCl, HPMC and 
lactose were assessed for bulk density, particle size distribution, flowability and friability. SEM, DSC, powder x-ray diffraction 
and drug dissolution studies were conducted to characterize the physical properties of the granules. Results: Type of 
granulating liquid affected the granule properties. The utilization of isopropyl alcohol as a granulating liquid and subsequently 
adding with water was a suitable system for agglomeration of powders. Good physical properties were obtained for the granule 
prepared by using this granulating fluid. Conclusion: Type of solvent and amount of water played an important role for physical 
properties of HPMC in the formation of the matrix granule due to the hydrophilicity and gel formation of this polymer. The use of 
isopropyl alcohol as granulating liquid and subsequently adding with water was a suitable process in producing the matrix 
granules consisting of HPMC.  
Keywords: hydroxypropyl methylcellulose, matrix granule, granulating fluid  
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Introduction
§Oral matrix system is the most popular form among 
sustainable release dosage forms in terms of 
effectiveness in controlling drug release and economics 
in manufacturing process. The matrix device consists of 
drug particles dispersed homogenously at molecular or 
particular level throughout a polymer matrix.1 Oral 
controlled-release dosage forms are able to improve the 
patient compliance due to a reduced dosing frequency. 
Furthermore, these systems might provide a decrease of 
incidence or intensity of the side effect, prolonged 
therapeutic effect, as well as an increase of cost 
                                                 
§ 14th year of Srinakharinwirot Journal of Pharmaceutical Science 
effectiveness. Solid oral controlled-release dosage forms 
are available either as single-unit or multiple-unit. The 
gastro-intestinal tract dispersion of multiple-unit dosage 
forms also reduces the risk of local irritation of gastric 
mucosa and also promotes the drug absorption.2  
Multiple-unit dosage forms could be prepared in form 
of pellet, granule, multi-particulate and mini-tablet. 
Granule could be produced by wet and dry granulation 
techniques. Addition of hydrophilic polymer as matrix 
component might prolong the drug release from the 
granule. Hydrophilic matrix has become extremely 
popular in controlling rate of drug release from solid 
dosage forms. Hydroxypropyl methylcellulose (HPMC) 
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has been employed extensively as a hydrophilic matrix 
former in the oral controlled-release dosage forms for 
various drugs including propranolol HCl. Its popularity 
can be attributable to its non-toxic nature, small influence 
of processing variables on drug release, ease of 
compression, and capability to accommodate a high level 
of drug loading.3,4  
The use of water as the granulating liquid for 
hydrophilic matrix compositions could give the lump 
formation5, but some research claimed that water could 
be employed for this purpose. Steam granulation was 
attempted as an alternative granulation technique to 
improve the dissolution of poorly soluble drug.6,7 When 
the HPMC particles are exposed to the water during the 
granulation, a highly viscous gel layer forms around 
them. The granule produced from low molecular weight 
HPMC using water as granulating liquid was less 
compact with poor flowability and lower bulk density. This 
is because this polymer had lower viscosity and thinner 
gel layer, which consequently promoted the lower 
adhesion between particles.8 The poor water uptake 
owing to the gel-forming property of HPMC retarding the 
water penetration affected the wettability of the powder 
mixture and granule formation.9 The water uptake, gelling 
rate and viscosity were the important factors affecting the 
granule formation.10 Because of high hydration and gel 
forming properties of HPMC after contact with water, the 
sticky mass was formed and it was difficult to pass 
through the screen to form the granule. Therefore, this 
study wished to select the suitable solvent system for 
producing the granule consisting of HPMC with 
diminishment of lump formation.  
Propranolol hydrochloride is a β-adrenergic blocking 
agent, i.e. a competitive inhibitor of the effects of 
catecholamines at β-adrenergic receptor sites. It is widely 
used in therapeutics for the antihypertensive, anti-
angorous and antiarrhythmic properties. Furthermore, 
with its short elimination half-life of 3 hours11, it is a 
suitable model drug to be developed into prolonged 
release dosage form.  
In this study, the assessment of the different solvent 
systems was performed to select the suitable granulating 
fluid for producing the propranolol HCl granule containing 
HPMC as matrix component. The characterization of 
granule prepared from different solvents was carried out. 
 
Material and Methods 
Materials 
Propranolol hydrochloride (lot no. 941002, China 
National Chemical Imp. Exp., China), hydroxypropyl 
methylcellulose K 15M (Methocel® K 15M) (lot no. NH 
16012N11, Colorcon Asia Pacific Pte. Ltd.) and 
Emcompress® (Mendell, Bodenheim, Germany) were 
used as received. Dichloromethane (lot no. 02110176, 
Reagent Chemical Industry Ltd., Thailand), ethanol (lot 
no. 0501252, VWR International Ltd., England), isopropyl 
alcohol (lot no. K33157272, VWR International Ltd., 
England) were used as granulating fluid. HCl solution (lot 
no. A01025, Baker Analyzed® A.C.S. Reagent, USA), 
monobasic potassium phosphate (lot no. 45-2, P.C. Drug 
Center Co. Ltd., Thailand), sodium hydroxide pellet (lot 
no. 03/07/157A) and sodium chloride (lot no. 1149, P.C. 
Drug Center Co. Ltd., Thailand) were purchased from 
P.C. Drug Center Co. Ltd., Thailand. HPMC capsule no. 
1 (Capsugel, Thailand) and NP™ capsule no. 1 
(Capsugel, Thailand) were used as received. 
 
Determination Solubility Property of HPMC   
Solubility of HPMC in various solvents was 
determined. The solubility data were utilized to select the 
granulating liquids for producing the granules. The 
solvents used in this determination were considered 
based on solubility and viscosity of HPMC. The 
employed liquids were water, 95% ethanol, 
dichloromethane, isopropyl alcohol (IPA), mixtures of 
ethanol (E) and dichloromethane (D), and mixtures of 
IPA and water. HPMC powder (3 g) was dispersed in 
150 ml of various liquid and stirred with magnetic stirrer 
for 24 hours in the closed container. The appearance of 
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mixture was observed and then the viscosity was 
measured using Brookfield viscometer (Brookfield 
Engineering Laboratories Inc., USA.) (n = 3).  
 
Preparation of Matrix Granules 
13.34-g propranolol HCl, 21.67-mg HPMC (25% of 
diluent) and 64.99-mg lactose (75% of diluent) were 
mixed for 5 minutes using mortar and pestle. Matrix 
granules were prepared by wet granulation method. All 
materials were mixed in a porcelain mortar by geometric 
dilution and then wetted with granulating liquid in 
sufficient quantity to achieve the funicular state of 
agglomeration. The liquids employed in wet granulation 
were water, 95% ethanol, dichloromethane, isopropyl 
alcohol (IPA), mixtures of ethanol and dichloromethane, 
and mixtures of isopropyl alcohol and water. The wet 
mass was passed through a sieve No. 20 mesh and 
dried in a hot air oven at 50 °C for 5 hours, then left to 
cool down to room temperature. The dried granules were 
rescreened through the sieve No. 20 mesh. The 
prepared granule was filled into capsule No. 1 using 
capsule filling machine No. 1 (S.T.P. No.1 B.M., 
Thailand) which one capsule contained 40-mg 
propranolol HCl and 25% HPMC, and lactose 75% were 
used as diluent. To decrease the adhesion of the 
granules during dissolution test, 10% polyplasdone XL 
was mixed with the granules and added into the capsule. 




Evaluation of Physical Properties of Matrix 
Granules 
 
Bulk Density of Granules 
The bulk density of granules was determined by 
pouring 10 g of the granules into a 50 mL cylinder and 
measuring the volume of granules. Tapped density was 
determined after tapping the cylinder until no further 
decrease in the granule volume. The Carr’s 
(compressibility) index was calculated from the following 
equation: 
 
Carr’s index = tapped density – bulk density × 100   (eq. 1) 
tapped density 
 
This index is interpreted in the following way: the 
higher the compressibility index, the poorer the 
flowability.  
 
Particle Size Distribution 
Particle size distribution was determined by sieve 
analysis. The set of standard sieve consisted of sieves 
No. 20, 40, 60, 80, 100, 200 mesh and collection pan 
respectively. Approximately 20 g of granules were put on 
the top sieve series. The sieve series was placed on the 
sieve shaker and shaken for 5 minutes. The granules 
retained on each sieve size were weighed and calculated 
in percentage of total weight. These values were plotted 
against particle size. 
 
Flowability 
The angle of repose was used to determine the 
flowability of powder and granules. The angle of repose 
was measured from pouring the granules into a teflon 
pipe (3-inch height and 4.3-cm diameter) which was 
placed on a graph paper. Then the teflon pipe was 
raised up. The angle of repose (θ) was then calculated 
as tan θ = h/r; where h and r equaled height and radius 
of the cone respectively.  
 
Friability 
The friability of granules was determined by a 
friabilator (Yieheng Engineering, Bangkok, Thailand). 
One gram of granules with average particle size of 850 
µm was accurately weighed by an analytical balance. 
This weight was designated as W0. The granules were 
filled into a spherical container and rotated at 25 rpm for 
4 minutes with friabilator. These granules were 
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rescreened through sieve No. 40 mesh and reweighed 
“W”. The percent of friability was calculated based on the 
following equation. The result was obtained from the 
average of three determinations. 
 
% Friability = {(W0 – W)/ W0} × 100   (eq. 2)   
 
Determination of Shape and Surface Topography 
of Granules 
The shape and surface topography of prepared 
granules were analyzed with scanning electron 
microscopy (SEM) (Maxim 200 Camscan, Cambridge, 
England). The samples were stuck on a metal stub using 
carbon double adhesive tape and sputter-coated with 
gold before test. Micrographs were taken with a scanning 
electron microscope operated at an accelerating voltage 
of 20 KeV.  
 
The Differential Scanning Calorimetry (DSC)  
The DSC curves of drug, HPMC, prepared granules 
and physical mixture of these substances as the same 
ratio in the granule were obtained using a differential 
scanning calorimeter (DSC) (Pyris Sapphire DSC, 
Standard 115V, Perkin-Elmer Instruments, Japan). 
Samples of approximately 5 mg were weighed into non-
hermetically sealed aluminium pans. The experiment was 
done between 25 °C and 250 °C with a heating rate of 
10 °C/min and using nitrogen as a purge gas (20 
mL/min).  
 
The Powder X-ray Diffraction 
The powder X-ray diffractometer (Diffractometer DS, 
Bruker, AXS, Germany) was used to determine the 
crystalline transformation and interaction between each 
component after mixing and wet granulating processes. 




Study of Drug Release  
The dissolution of propranolol hydrochloride was 
performed with the basket method using a dissolution 
apparatus (type 1) (Prolabo, France). The dissolution 
fluid used was 900 mL HCl buffer pH 1.2. The speed of 
basket rotation was 100 rpm maintained at 37 °C. The 
amount of propranolol hydrochloride was 40 mg per 
capsule for all formulations. The samples were withdrawn 
at predetermined time intervals. The amount of drug 
released was measured using UV spectrophotometer 
(Perkin-Elmer, Germany) at 320 nm. The cumulative 
percentage of propranolol hydrochloride released was 





Solubility of HPMC 
The physical appearances of systems containing 
HPMC in various solvents are shown in Figure 1. HPMC 
could form a viscous colloidal solution in water and 
mixtures of ethanol and dichloromethane (E:D) in ratios 
of 50:50, 40:60 and 30:70 (Figure 1A, 1B). There was a 
precipitation of HPMC powder in ethanol and isopropyl 
alcohol (Figure 1A, 1C). The viscosity values of systems 
containing HPMC are shown in Table 1. The viscosity of 
HPMC solution in different types of liquid were ranked as 
water > E:D (40:60) > E:D (30:70) > E:D (50:50) > E:D 
(60:40) > IPA-water (10%) mixture > E:D (70:30) > IPA > 
dichloromethane > ethanol, respectively. HPMC could be 
soluble in water and in mixtures of ethanol and 
dichloromethane in ratios of 50:50, 40:60 and 30:70 
(Figure 1A). Moreover, by visual inspection it was 
partially soluble in dichloromethane, mixtures of ethanol 
and dichloromethane in ratios of 70:30 and 40:60, and 
mixture of isopropyl alcohol and water (10%) (Figure 1) 
but it was insoluble in ethanol and isopropyl alcohol.  
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Figure 1 Appearance of systems containing 2% w/v Methocel K 15M in various liquids; (A) 
ethanol, dichloromethane, mixtures of ethanol and dichloromethane in ratios of 
50:50, 70:30, 60:40, 30:70 and 40:60 respectively (left to right); (B) water; (C) 
isopropyl alcohol and (D) mixtures of isopropyl alcohol and water (10%).   
 
 
Table 1 Viscosity of the systems containing HPMC in 
various solvents.  
Solvent Viscosity (mPa·s) 
(mean ± S.D. ) (n = 3) 
Ethanol 95% (E) 6.53 ± 0.31 
Dichloromethane (D) 7.47 ± 0.12 
E:D (50:50) 263.73 ± 16.48 
E:D (70:30) 12.60 ± 0.35 
E:D (60:40) 32.20 ± 1.20 
E:D (30:70) 1092.00 ± 26.00 
E:D (40:60) 1210.67 ± 18.90 
Water  2686.67 ± 18.90 
Isopropyl alcohol (IPA) 10.13 ± 0.46 
IPA + water (10%) 13.60 ± 0.20 
 
 
Characterization of Granules 
Initially, the preparation of granules containing 
propranolol HCl, lactose and HPMC was attempted using 
water as granulating liquid. A large amount of lump 
appeared during the preparation of the wet mass and it 
was difficult to pass through a sieve to form the granules 
(Figure 2A, 2B). Therefore, an organic solvent was used 
as a solvent for granulating fluid. The first organic solvent 
used was 95% ethanol but a large volume of ethanol 
was needed. The solid mixture was rather difficult to be 
wet and a large amount of fine powder was evident. An 
addition of the water into the system using 95% ethanol 
as granulating fluid resulted in the lump formation similar 
to the system using water (Figure 2D). Hence, the 
addition of water in wet granulation process containing 
HPMC generated the problem mentioned above. The 
systems containing HPMC in the mixtures of ethanol and 
dichloromethane in ratios of 50:50, 40:60 and 30:70 
exhibited viscous solution similar to the system 
containing HPMC dispersed in water. The solvent 
systems were further utilized as a granulating fluid since 
they could promote the good granule formation without 
losing wet mass owing to the lump formation. Therefore, 
the mixtures of ethanol and dichloromethane could be 
applied as granulating fluid. Especially, the E:D mixtures 
in the ratios of 50:50 and 40:60 provided the granules 
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with good appearance but the mixture of E:D in a ratio of 
30:70 notably provided a lot of fine particles in the 
granulation process (Figure 3A, 3B, 3C).  
The utilization of isopropyl alcohol as granulating liquid 
to produce tablets comprising HPMC K4M by wet 
granulation method has been previously reported.12 
Isopropyl alcohol was demonstrated to be used as 
granulating fluid in this experiment. Apparently, an 
amount of isopropyl alcohol used for agglomeration of 
powder mixture to obtain the wet mass was less than 
that of ethanol. Moreover, it exhibited a good wetting, i.e. 
slower evaporation, than ethanol, thereby HPMC powder 
could not swell. After screening, the system contained 
large amount of somewhat fine particles (Figure 3D). 
Therefore, water in an amount of 10% (v/v) was added to 
the solid mixture. By visual inspection, there was a less 
swelling of solid mixture, but the agglomeration of solid 
mixture could be formed. The lump formation 











(C)  (D) 
Figure 2 Appearance of propranolol HCl granules prepared using two different granulating liquids; 
1) water: in form of (A) granules, (B) wet mass and 2) mixtures of ethanol and water: in 
form of (C) granules and (D) wet mass.  












(D)  (E) 
Figure 3 Appearance of propranolol HCl granules prepared using different granulating liquids; 
mixtures of ethanol and dichloromethane in ratios of 50:50 (A), 40:60 (B) and 30:70 (C), 
isopropyl alcohol (D),  and isopropyl alcohol subsequently added with water (10% v/v) (E).  
 
 
Particle Size Distribution and Granule Friability 
The particle size distribution of the granules made 
from different granulating liquids, i.e. mixtures of ethanol 
(E) and dichloromethane (D) in the ratios of 50:50, 40:60, 
30:70 and isopropyl alcohol subsequently added with 
water in the amount of 10% v/v, is shown in Figure 4. 
The particle size distributions of most granules that were 
rescreened through sieve No. 20 mesh were 425 - 850 
µm. The utilization of E:D (50:50) as granulating liquid 
provided granules with obviously larger particle size (850 
µm) than isopropyl alcohol with water subsequently 
added in the amount of 10%v/v did with the particle size 
of 425 µm. The particle size of Emcompress was not 
determined in this investigation; however the typical 
Emcompress has the median particle size of 130 - 150 
µm. The % friability of the granules made from different 
granulating liquids were ranked as E:D (30:70) > E:D 
(60:40) > E:D (50:50) > IPA + water (10% v/v), 
respectively (Table 2). This result signified that the 
granules produced by using isopropyl alcohol with water 
subsequently added in an amount of 10% v/v as 
granulating liquid were harder than those produced by 
other solvents.  
 
Table 2 Friability of propranolol HCl granules produced 
using different granulating liquids.  
% Friability (n = 3) 
Granulating liquid 
Mean S.D. 
E:D (50:50) 10.14 1.01 
E:D (40:60) 10.48 0.58 
E:D (30:70) 16.49 2.09 
IPA + water (10% v/v) 7.14 1.01 
Note: E = ethanol, D = dichloromethane, IPA = isopropyl alcohol.   
 
 























Figure 4 Particle size distribution of propranolol HCl granules made from different granulating liquids. 
                   Note: E = ethanol, D = dichloromethane  
 
 
Bulk density, tapped density, compressibility index and angle of repose 
Emcompress granules were used as a reference for 
testing the physical properties of granules in this 
experiment. The bulk and tapped densities of the 
granules made from different granulating liquids are 
presented in Table 3. The bulk and tapped densities of 
granules which were screened through sieve No. 40 
mesh were higher than the granules that were screened 
through sieve No. 20 mesh. The Carr’s indexes of 
powders were higher than that of all prepared granules 
and Emcompress granules. This result indicated that the 
prepared granules had better flow properties than the 
powders. The Carr’s index of the granules produced from 
the granulating fluid containing mixtures of ethanol and 
dichloromethane in the ratios of 50:50 and 40:60 and 
isopropyl alcohol and water subsequently added in the 
amount of 10% v/v after rescreening through sieve No. 
20 mesh were 6.47, 8.33 and 3.92%, respectively. 
Therefore, these granules exhibited the fairly good flow 
properties as classified by another researcher.13 Because 
of the smaller granules size, the Carr’s index of 
Emcompress granules was higher than that of the 
prepared granules. There was a high value of Carr’s 
index of the granules made from mixtures of ethanol and 
dichloromethane in a ratio of 30:70 and the granules 
screened through sieve No. 40 mesh before test. This 
might be due to the formation of the large amount of fine 
particles during granulation. The angle of repose of 
powders and the granules made from different 
granulating liquids are reported in Table 2. The angle of 
repose of the granules (29° - 34°) exhibited lower value 
than the powder (37° - 40°), indicating better flow 
properties for all prepared granules. 
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Table 3 Flow properties of propranolol HCl granules prepared from different granulating liquids. 
Granulating liquid Bulk density (g/mL) (n = 3) 
Tapped density 
(g/mL) (n = 3) 
Carr's index (%) 
(n = 3) 
Angle of repose 
(θ) (n = 3) 
Propranolol HCl powder 0.30 ± 0.01 0.42 ± 0.00 28.90 ± 0.89 37.31 ± 2.34 
HPMC powder 0.30 ± 0.01 0.46 ± 0.01 34.48 ± 1.98 38.22 ± 3.15 
Lactose powder 0.45 ± 0.01 0.67 ± 0.00 32.81 ± 1.71 40.36 ± 0.00 
Emcompress granules 0.91 ± 0.00 1.00 ± 0.00 9.06 ± 0.05 26.26 ± 0.53 
E:D (50:50), 20# passed*  0.35 ± 0.01 0.38 ± 0.01 6.47 ± 0.97 31.90 ± 2.37 
E:D (50:50), 40# passed* 0.41 ± 0.01 0.48 ± 0.01 15.50 ± 2.78 27.77 ± 0.52 
E:D (40:60), 20# passed* 0.36 ± 0.00 0.39 ± 0.00 8.33 ± 1.03 31.23 ± 1.27 
E:D (30:70), 20# passed* 0.38 ± 0.02 0.43 ± 0.01 10.88 ± 0.79 29.25 ± 0.00 
IPA, 20# passed* 0.40 ± 0.01 0.50 ± 0.01 18.79 ± 1.07 33.02 ± 0.70 
IPA + water (10%), 20# passed* 0.39 ± 0.01 0.41 ± 0.01 3.92 ± 1.89 29.80 ± 1.94 
IPA + water (10%), 40# passed* 0.43 ± 0.01 0.50 ± 0.00 14.25 ± 2.09 30.11 ± 0.00 
Note: E = ethanol, D = dichloromethane  





Scanning electron micrographs of the granules 
produced from the mixtures of ethanol and 
dichloromethane in the ratios of 50:50 and 40:60 are 
presented in Figure 5A-D. All granules obtained from the 
agglomeration of particles exhibiting porous surface. 
After rescreening, the granules were smaller and more 
spherical characteristics. The surface of the granules 
produced by using isopropyl alcohol as granulating liquid 
and subsequently added with water in the amount of 
10% v/v showed the dense agglomerated particles and 
exhibited the less porous surface than the granules that 
were produced by using mixtures of ethanol and 
dichloromethane in the ratios of 50:50 and 40:60 (Figure 
5G-H, 6A-C). On the other hand, scanning electron 
micrographs of the granules made from isopropyl alcohol 
exhibited fine particles and wide size distribution (Figure 
5E-F). 


















(G)  (H) 
 
Figure 5 Scanning electron micrographs of propranolol HCl granules produced from 4 granulating liquids (10X): 1) 
mixtures of ethanol and dichloromethane in a ratio of 50:50: (A) after drying, and (B) rescreened through 
sieve No. 20 mesh; 2) mixtures of ethanol and dichloromethane in a ratio of 40:60: (C) after drying, and (D) 
rescreened through sieve No. 20 mesh; 3) isopropyl alcohol: (E) after drying, and (F) rescreened through 
sieve No. 20 mesh; 4) isopropyl alcohol with water subsequently added in an amount of 10% v/v as 
granulating liquid: (G) after drying, and (H) rescreened through sieve No. 20 mesh.  
 





(A)  (B) 
 
 
(C)   
Figure 6 Scanning electron micrographs of propranolol HCl granules produced using isopropyl alcohol 
with water subsequently added in an amount of 10% v/v as granulating liquid and rescreened 
through sieve No. 40 mesh with different magnifications: (A) 10X, (B) 100X, and (C) 400X.  
 
 
Differential Scanning Calorimetry (DSC)  
The DSC curves of propranolol HCl, HPMC, lactose, 
physical mixture and granules produced by using 
isopropyl alcohol with water subsequently added in an 
amount of 10% v/v as granulating liquid are shown in 
Figure 7. Propranolol HCl and HPMC exhibited the 
endothermic peak at 163.6 °C and 49.8 °C, respectively. 
The DSC curve of lactose showed two dominant 
endothermic peaks at 149.5 °C and 217.9 °C. From the 
DSC curves of physical mixture between drug and 
excipients, all major peaks of each component could still 
be detected. Propranolol HCl granule showed the 
characteristic peaks of each component in the 
formulation in DSC curves. This phenomena were also 
found in DSC curve of the prepared granules but the 
intensity of drug melting point in granules prepared by 
using a mixture of ethanol and dichloromethane (50:50) 
(data not shown) and isopropyl alcohol with water was 
less than that of physical mixture.  
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Figure 7 Differential scanning calorimetry thermograms of (A) lactose; (B) HPMC K15M; (C) propranolol 
HCl; (D) physical mixture; and (E) granule produced using isopropyl alcohol with water 
subsequently added in an amount of 10% v/v as granulating liquid.  
 
 
Powder X-ray Diffraction 
The powder X-ray diffraction patterns of propranolol 
HCl, HPMC K15M, lactose and physical mixture are 
presented in Figure 8. The X-ray diffraction patterns of 
propranolol HCl matrix granules prepared with different 
granulating liquids are shown in Figure 9. The X-ray 
diffraction pattern of propranolol HCl displayed peak at 
diffraction angle between 10°2θ and 30°2θ. The X-ray 
diffraction pattern of lactose showed sharp peak at 
diffraction angle between 18°2θ and 22°2θ. However, 
the characteristic peaks of physical mixture did not 
present a different peak from pure propranolol HCl, 
lactose or HPMC peak. The X-ray diffraction pattern of 
propranolol HCl matrix granule was not different from 
physical mixture but the peak intensity at diffraction angle 
about 38°2θ was decreased. This might be due to partial 
solubilization of this substance in these granulating 
liquids.  
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Figure 8 X-ray diffraction spectra of (A) lactose, (B) HPMC K15M, (C) propranolol HCl, 
and (D) physical mixture.   
 
 
Figure 9 X-ray diffraction spectra of propranolol HCl matrix granule made with different 
granulating liquids; (A) physical mixture, (B) water, (C) IPA, (D) IPA-water, 
and (E) ethanol with dichloromethane (50:50).  
 
Drug Release 
The release of propranolol HCl from granules filled into 
NP caps™ was faster than that of the granules filled into 
HPMC capsule (Figure 10). The granules filled into 
HPMC capsule exhibited a tendency to adhere to one 
another, because HPMC capsule hydrated more slowly 
than NP caps™. On the other hand, the NP caps™ 
could disintegrate quickly when it contacted the 
dissolution medium. Therefore, the NP caps™ capsule 
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was chosen for development of the multiple-unit 
preparations. The polyplasdone XL which is a 
superdisintegrant was used to add into multiple-unit 

















Figure 10 Dissolution profiles of propranolol HCl released from HPMC matrix granules 




Effect of Granulating Liquid on Granule Formation 
The propranolol HCl powder component containing 
25% HPMC and 75% lactose was used as the matrix 
granule. Utilization of water as granulating liquid in wet 
granulation method led to the large amount of lump 
formation in wet mass. This wet mass was difficult to 
pass through sieve to form the granules due to 
hydrophilicity and gel formation of HPMC in the 
formulation. HPMC could be soluble in the mixtures of 
ethanol and dichloromethane in ratios of 50:50, 40:60 
and 30:70, as well as in the water. However, viscosity of 
HPMC solution using these liquids was lower than that in 
the water. This result indicated that the degree of 
swelling of HPMC in mixtures of ethanol and dichloro-
methane was less than that in the water. Ethanol and 
dichloromethane were rapidly evaporated. Thus, the 
utilization of mixtures between ethanol and dichloro-
methane in the ratios of 50:50, 40:60 and 30:70 as 
granulating liquid provided the granules with a good 
characteristic thereby the lump formation did not occur.  
In addition, isopropyl alcohol could be used for 
agglomeration of powder mixture since it exhibited a 
good wetting and slower evaporation than ethanol. The 
lump formation disappeared but the large amount of fine 
particle occurred when isopropyl alcohol was utilized as 
granulating liquid. In order to increase a binding property, 
the water was added about 10% (v/v). HPMC could act 
as its own binder by forming a gel layer when contacting 
with water.14 Therefore the water was an important factor 
in the HPMC matrix granule preparation.  
 
Effect of Granulating Liquid on Granule Properties 
During the wet mass granulation and the stages of 
drying, the drug and any soluble excipients will dissolve, 
recrystalize, and then form solid interparticulate bridges 
after the binder vehicle is evaporated. The strength of 
the crystalline bridges depends on the amount of solid 
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deposition and rate of crystallization. Both properties are 
dependent on the solubility of the drug and other 
excipients in the granulating solvent.15 The granules 
produced by using the mixtures of ethanol and 
dichloromethane in the ratios of 50:50 and 40:60 had an 
obviously porous surface because lactose in the 
formulation was not soluble in the mixture of ethanol and 
dichloromethane in the ratio of 50:50 while HPMC and 
propranolol HCl could dissolve in this liquid (Figure 11 - 
12).  
Lactose or propranolol HCl powders (3 g) were 
dispersed in 150 mL of solvent and stirred with magnetic 
stirrer for 24 hours before this visual observation. 
Therefore, solid interparticulate bridges of the granules 
might be less compact and this resulted in a more 
porous surface of the granules. Moreover, the 
percentage of friability of these granules was higher than 
that of the granule matrix producing by using isopropyl 
alcohol subsequently added with water (10% v/v). The 
surface of the granules produced by using isopropyl 
alcohol with water (10% v/v) showed the dense 
agglomerated particles and exhibited the less porous 
surface than the granules produced with mixtures of 
ethanol and dichloromethane in the ratios of 50:50 and 
40:60. Basically, lactose and propranolol HCl could be 
soluble in the former solvent (Figure 11 - 12) and HPMC 
in formulation also acted as binder after exposure to the 
water. This resulted in the stronger bonding according to 
adhesion and cohesion forces between particles 
promoting the lower percentage of friability of granules. 
Wells and Walker (1983)16 has previously reported the 
effect of wet-massing acetylsalicylic acid with aqueous 
and hydroalcoholic solutions of PVP which the greater 
drug solubility produced the granules of larger size, low 
particle size distribution and reduced the friability. 
Therefore, using isopropyl alcohol with water 
subsequently added (10% v/v) as granulating liquid was 
the appropriate system in wet granulation method in this 
experiment. This granulating liquid was selected for 




Figure 11 Appearance of systems containing lactose in 
water, 50:50 ethanol and dichloromethane, 
90:10 isopropyl alcohol and water, and IPA, 
respectively (left to right).  
 
   
Figure 12 Appearance of systems containing propranolol 
HCl in IPA, 90:10 isopropyl alcohol and 
water, water, and 50:50 ethanol and dichloro-
methane, respectively (left to right).  
 
 
The DSC curve of physical mixture (propranolol HCl, 
HPMC and lactose) and the matrix granule exhibited all 
major peaks of each component indicating the substance 
in the mixtures to be compatible. The DSC curve of 
lactose exhibited two endothermic peaks. The first and 
second endothermic curves corresponded to the loss of 
crystalline water and the melting of lactose followed by 
its decomposition, respectively.17 From X-ray powder 
diffractograms, propranolol HCl and lactose showed a 
crystalline characteristic. The intensity of diffraction 
peaks of propranolol HCl in matrix granule at diffraction 
angle about 38°2θ was decreased. This might be due to 
partial solubilization of this substance in the granulating 
liquids. The decrease of crystallinity of soluble substance 
has been previously reported in case of increasing the 
temperature during mixing the granule containing HPMC 
with high-shear granulator.18 
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The propranolol HCl matrix granule containing HPMC 
was developed as multiple-unit dosage form. The 
prepared granules were filled into NP cap™ capsule 
since this capsule could disintegrate quickly after 
contacting the dissolution medium. The polyplasdone XL 
was used to add into multiple-unit formulation as 
superdisintegrant to decrease the adhesion of the 
granules during dissolution test. The initial drug release 
from the granule containing 75% lactose and 25% HPMC 
was rather fast because of high surface area and the 
presence of water-soluble filler. Therefore, more amount 
of polymer in matrix component or surface coating may 
be needed for prolongation of drug release from this 
granule. The diminishment of surface area by tabletting 
the obtained granule should prolong the drug release. 
However, our on-going research will concentrate on the 
incorporation of hydrophobic wax into this HPMC matrix 
granule to modulate the drug release.  
 
Conclusion 
Type of granulating liquid influenced the granule 
properties. The system containing isopropyl alcohol and 
water was a suitable granulating liquid for agglomeration 
of powders in which water was the important factor in 
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